Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by venture009on Sep 21, 2023 10:32am
140 Views
Post# 35647279

RE:RE:RE:RE:Oh not again...

RE:RE:RE:RE:Oh not again...Azzak34, Quentin30 has history on his side. "Those that do not learn from history are doomed to repeat it." It's hard to argue the fact about no large institutional investors stepping up especially after the panc trials and then the company making a deal that looks like a fire sale at $2.26 a share. 
Over the years ONCY has had numerous "fireside chats" and non have yielded anything of significance to propel the share price. Since the beginning of 2023 the consenses has been for a buyout or the very least a partner. These "fireside chats" are focused on stirring up investor interest, not something you would expect if talks with BP were close to a deal. These recent actions by management are disappointing. Like most, I was hoping for a buyout and a final end to this circus. The market reaction has always been correct and currently with the low trading volume there isn't much optimism. So far the "garbage losers" are the shareholders. Finally management aren't stepping up to support the sp and never have. Why?
<< Previous
Bullboard Posts
Next >>